Published Date: 26 Apr 2023
While a trip to the dentist for tooth sensitivity may occasionally reveal the dreaded cavity, other things may be to blame for the sharp zings and dull aches brought on by extreme cold and heat.
Read Full NewsModelling shows fewer cases and deaths with screening starting at age 45 years.
A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared with lenalidomide alone in patients with multiple myeloma.
Although many surgeons avoid it, nipple-sparing mastectomy after radiation is a feasible alternative to skin-sparing mastectomy and may help preserve patients’ psychological well-being.
1.
Ranking of the Best US Hospitals for Psychiatric Care.
2.
Screening for prostate cancer: is it time to give up digital rectal examination?
3.
US Counties Suffered Significantly from a Lack of Psychiatric Care.
4.
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC
5.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
1.
Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management
2.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
3.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
4.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
5.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation